Key result
CMR fails to differentiate giant cell myocarditis from cardiac sarcoidosis due to highly similar phenotypes.
Why the study?
Little is known about the CMR appearance of giant cell myocarditis and its ability to distinguish it from cardiac sarcoidosis.
Does cardiovascular magnetic resonance imaging distinguish between giant cell myocarditis and cardiac sarcoidosis?
Population
40 patients with endomyocardial biopsy-proven GCM (n = 14) and CS (n = 26)
Comparison
GCM vs CS clinical and CMR characteristics
Design
Blinded observational study
Authors
Loading...
CMR features in biopsy-proven GCM and CS may aid differentiation; larger prospective studies needed before clinical adoption.
Observational (n=40)
Blinded image analysis
No
Does cardiovascular magnetic resonance imaging distinguish between giant cell myocarditis and cardiac sarcoidosis?
Absolute Event Rate: 71% vs 77%
p-value: p=0.702
CMR imaging features are highly similar between giant cell myocarditis and cardiac sarcoidosis, making differentiation based solely on imaging challenging despite more severe clinical presentation in GCM.
Bobbio et al. (2023) conducted an observational in Giant cell myocarditis and cardiac sarcoidosis (n=40). Giant cell myocarditis vs. Cardiac sarcoidosis was evaluated on Presence of the 'hook sign' on cardiovascular magnetic resonance (p=0.702). Giant cell myocarditis and cardiac sarcoidosis demonstrated highly similar cardiovascular magnetic resonance phenotypes, including the presence of the 'hook sign' (71% vs 77%, p=0.702), making differentiation by imaging alone challenging.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: